Abstract:Background: Aneurysm subarachnoid hemorrhage (aSAH) is a life-threatened disease. Stress responded hyperglycemia following aSAH was one of most important predictors that was associated with poor outcomes and higher mortality of patients critically suffered from aSAH. Thus, optimal glucose management strategy could improve outcomes of aSAH patients in Neurocritical Care Unit (NCU). However, it’s still lacks of evidence on glucose level which is beneficial for severe aSAH patients. Recently, glucose variability (GV) was not only used to predict clinical outcomes and mortality, but also used as a more appropriated clinical target than blood glucose range only to manage glucose level. Our study aimed to find a relatively suitable glucose control for aSAH patients in NCU. Method: 332 patients were recruited from a retrospectively collected database of all patients with aneurysm SAH (aSAH) who were admitted to Tiantan Hospital in Beijing, China between January 2015 and December 2017. We collected continuous 14-day blood glucose and calculated glucose variability. Continuous 14-day blood glucose level were divided into four groups: stable, unstable, well-controlled, bad-controlled. Other predictor variables also included admission Hunt and Hess grade, age, gender, cardiovascular risk factors, and surgical treatment. In-patient mortality was the main outcome measure. Results: Univariate survival analysis showed that the stable and well-controlled groups have higher percentage of cumulative survival than the rest two groups. Then, Multivariate COX regression analysis showed that Hunt Hess scale (HR 2.666, 95% CI, 1.438-4.944), receiving Surgery (HR 0.073, 95% CI, 0.025-0.219), having hydrocephalus (HR 3.844, 95% CI, 1.038-14.228), bleeding in cisterna ambiens (HR 8.288, 95% CI, 2.270-30.259),bad-controlled glucose (HR 5.788, 95% CI, 1.441-23.237) and unstable glucose (HR 15.403, 95% CI, 2.666-88.987). Conclusions: GV is helpful to predict aSAH mortality, either long-term or short-term. Glucose fluctuated between 7 and 10 mmol/L is associated with better 14-day clinical outcomes for critically ill aSAH patients in NCU. Funding Statement: None. Declaration of Interests: The authors declare that they have no conflict of interest. Ethics Approval Statement: This retrospective study was approved by the Ethics Committee at the Tiantan Hospital in Beijing, in accordance with the Declaration of Helsinki; patient informed consent was not required because of the anonymous nature of the data.

Usefulness of plasma glucose to potassium ratio in predicting the short-term mortality of patients with aneurysmal subarachnoid hemorrhage

The association between serum glucose to potassium ratio on admission and short-term mortality in ischemic stroke patients

Serum glucose-potassium ratio predicts inhospital mortality in patients admitted to coronary care unit

Association between serum glucose potassium ratio and mortality in critically ill patients with intracerebral hemorrhage

Plasma gelsolin levels and outcomes after aneurysmal subarachnoid hemorrhage

The utility of serum glucose potassium ratio as a predictive factor for haemorrhagic transformation, stroke recurrence, and mortality among ischemic stroke patients

Relationship between serum glucose-potassium ratio and 90-day outcomes of patients with acute ischemic stroke

The blood glucose-potassium ratio at admission predicts in-hospital mortality in patients with acute type A aortic dissection

Association between the serum glucose-to-potassium ratio and clinical outcomes in ischemic stroke patients after endovascular thrombectomy

Association of Admission Serum Glucose-Phosphate Ratio with Severity and Prognosis of Aneurysmal Subarachnoid Hemorrhage

Admission Hyperglycemia Predicts Long-Term Mortality in Critically Ill Patients With Subarachnoid Hemorrhage: A Retrospective Analysis of the MIMIC-III Database

14-Day Continuous Glucose Level and Mortality in Aneurysm SAH: A Retrospective Study in Neurocritical Care Unit

Dynamic changes of platelets before and after surgery predict the prognosis of patients with aneurysmal subarachnoid hemorrhage

J-shaped association between serum glucose potassium ratio and prognosis in heart failure with preserved ejection fraction with stronger predictive value in non-diabetic patients

Relationship between the mean of 24-h venous blood glucose and in-hospital mortality among patients with subarachnoid hemorrhage: A matched cohort study

Association between high serum blood glucose lymphocyte ratio and all-cause mortality in non-traumatic cerebral hemorrhage: a retrospective analysis of the MIMIC-IV database

Performance comparison of stress hyperglycemia ratio for predicting fatal outcomes in patients with thrombolyzed acute ischemic stroke

Glucose fluctuation Impact on Delayed Cerebral Infarction and 30 Days Mortality in Aneurysm SAH: A Retrospective Study in Neurocritical Care Unit

Relationship between stress hyperglycemia ratio and prognosis in patients with aneurysmal subarachnoid hemorrhage: a two-center retrospective study

Plasma Anion Gap and Risk of In-Hospital Mortality in Patients with Acute Ischemic Stroke: Analysis from the MIMIC-IV Database

Retrospective Evaluation of Hematological and Clinical Factors Associated with 30-Day Mortality in 170 Patients Diagnosed with Intracerebral Hematoma in a Single Center in Turkey